Filing Details
- Accession Number:
- 0001209191-19-060285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-12 18:29:39
- Reporting Period:
- 2019-12-12
- Accepted Time:
- 2019-12-12 18:29:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326110 | Nantkwest Inc. | NK | Biological Products, (No Disgnostic Substances) (2836) | 431979754 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1424620 | C John Thomas | C/O Nantkwest, Inc. 3530 John Hopkins Court San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-12 | 10,000 | $1.99 | 360,069 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,886 | Indirect | See footnote |
Footnotes
- The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2019 by the reporting person.
- Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $1.98 to $2.01 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.
Billionaire Hedge Funds
